Nutrition · Medicines SafetyNutrisyon · Kaligtasan sa GamotNutrisyon · Kaluwasan sa TambalNutrisyon · Kaligtasan king Gamot

Hold the Ketoanalogue Until You See a NephrologistHuwag Munang Simulan ang Ketoanalogue Hangga't Hindi Nakikita ng NephrologistAyaw Usa Sugdi ang Ketoanalogue Hangtod Dili Ka Makita sa NephrologistAli Mu Pa Umpisan ing Ketoanalogue Anggang E Ka Pa Ikit ning Nephrologist

Before the tablets: establish the food plan, prevent accidental protein escalation, and protect nutrition.Bago ang tableta: buuin muna ang plano sa pagkain, iwasan ang di-sinasadyang pagdami ng protina, at protektahan ang nutrisyon.Una sa tableta: himoa una ang plano sa pagkaon, likayi ang wala tuyoa nga pagdaghan sa protina, ug panalipdi ang nutrisyon.Bayu ing tableta: buuan mu pa ing planu king pamangan, ilagan ing e sinadya a pamagdagul ning protina, at protektan ing nutrisyon.

Thinking of starting ketoanalogues?Balak mo bang magsimula ng ketoanalogue?Naghunahuna ka ba nga mosugod og ketoanalogue?Balak mu bang mumpisa king ketoanalogue? First arrange a kidney and nutrition review. Already taking a prescribed regimen? Contact your prescriber before changing it. Keep the diet plan and the tablets together.Unahin ang pagsusuri ng bato at nutrisyon. Umiinom ka na ayon sa reseta? Kausapin muna ang nagreseta bago ito baguhin. Panatilihing magkasama ang plano sa pagkain at ang tableta.Unaha ang pagsusi sa kidney ug nutrisyon. Nag-inom na ka sumala sa reseta? Kontaka una ang nagreseta sa dili pa usbon. Ipadayon nga magkauban ang plano sa pagkaon ug ang tableta.Unan mu ing pamanyalese king batu at nutrisyon. Mininum na ka ayun king reseta? Kausapan mu pa ing menyulat ning reseta bayu mu ban gulisan. Panatilian dang magkayabe ing planu king pamangan at ing tableta.

Summary

Practice. Ketoanalogues (KA) are an adjunct to a supervised low-protein or very-low-protein diet (VLPD) in selected adults with non-dialysis chronic kidney disease (CKD). Before a first prescription, document the food-protein and energy prescription, actual intake including shakes, a reference weight, a physical activity plan, the renal dietitian, and the monitoring owner.

Evidence. A selected-patient trial showed fewer kidney events with a supplemented vegetarian VLPD; a pragmatic trial of prescribing that strategy showed no added benefit. No trial supports tablets added to an unrestricted diet.

Safety. Ask about protein shakes and unsupervised food cutting, count supplemental calcium, and never tell a current user to stop without the prescriber.

PublishedNailathalaGipatikPepalwal: ReferencesMga SanggunianMga TinubdanReng Reperensya: 15 Read timeOras ng pagbasaOras sa pagbasaOras ning pamamasa:
Top-down view of a lined meal-plan notebook with pencil sketches of rice, vegetables and fish resting on top of a closed white box of tablets on a light kitchen counter, beside a teal pencil, a wooden spoon, a plain can, a glass of water, and a planned plate of rice, green vegetables and grilled fish.

A food plan comes before the tabletsNauuna ang plano sa pagkain bago ang tabletaMag-una ang plano sa pagkaon sa dili pa ang tabletaMamuna ing planu king pamangan bayu ing tableta

Ketoanalogues are tablets sometimes used together with a carefully planned diet in selected people with chronic kidney disease (CKD). Before starting them, your care team needs to know three things: what you actually eat, whether you are getting enough energy (calories), and who will follow your kidney function and nutrition afterward.Ang ketoanalogue ay tabletang ginagamit kung minsan kasabay ng maingat na planong diyeta sa piling taong may chronic kidney disease (CKD, pangmatagalang sakit sa bato). Bago ito simulan, kailangang malaman ng iyong team ang tatlong bagay: ano talaga ang kinakain mo, sapat ba ang enerhiya (calories) mo, at sino ang susubaybay sa iyong bato at nutrisyon pagkatapos.Ang ketoanalogue usa ka tableta nga usahay gigamit uban sa maampingong giplano nga diyeta sa pinili nga mga tawo nga adunay chronic kidney disease (CKD, dugay nga sakit sa kidney). Sa dili pa kini sugdan, kinahanglan mahibaloan sa imong team ang tulo ka butang: unsa gyud ang imong gikaon, igo ba ang imong enerhiya (calories), ug kinsa ang mosubay sa imong kidney ug nutrisyon human niini.Ing ketoanalogue metung yang tableta a gagamitan nung kapilan kayabe ning maingat a meplanung diyeta kareng piling tau a atin chronic kidney disease (CKD, malawig a sakit king batu). Bayu me umpisan, kailangan nang balu ning team mu ing atlung bage: nanu talaga ing pamangan mu, sapat ya ing kekang enerhiya (calories), at ninu ing manyubaybay king batu at nutrisyon mu kaibat.

⛔

The tablets are not a permission slipHindi pahintulot ang tabletaDili pagtugot ang tabletaE ya pamipalubus ing tableta

The tablets do not give you permission to eat extra protein. They also do not make it safe to cut protein or meals on your own.Hindi ka pinapayagan ng tableta na kumain ng dagdag na protina. Hindi rin nito ginagawang ligtas ang pagbawas ng protina o pagkain nang ikaw lang ang nagpapasya.Dili ka tugotan sa tableta nga mokaon og dugang nga protina. Dili usab niini himoong luwas ang pagkunhod sa protina o pagkaon nga ikaw ra ang nagdesisyon.E na ka pipalubusan ning tableta a mangan dagdag a protina. E na naman pagawang ligtas ing pamanibawas king protina o pamangan nung ika mu bisa ing magdesisyun.

⚠️

Already taking ketoanalogues?Umiinom ka na ng ketoanalogue?Nag-inom na ka og ketoanalogue?Mininum na kang ketoanalogue?

Do not stop on your own because of this guide, especially if you are on a very-low-protein diet. Bring your prescription, food plan, and supplement labels to your prescriber and ask whether the plan still fits you. “Hold” in the title means: do not start without a plan.Huwag itigil nang mag-isa dahil lang sa gabay na ito, lalo na kung nasa very-low-protein diet ka. Dalhin ang reseta, plano sa pagkain, at mga label ng supplement sa nagreseta at itanong kung akma pa ang plano sa iyo. Ang “Hold” sa pamagat ay nangangahulugang: huwag magsimula nang walang plano.Ayaw hunonga nga ikaw ra tungod lang niini nga giya, labi na kung naa ka sa very-low-protein diet. Dad-a ang reseta, plano sa pagkaon, ug mga label sa supplement ngadto sa nagreseta ug pangutan-a kung haom pa ba ang plano kanimo. Ang “Hold” sa titulo nagpasabot: ayaw pagsugod nga walay plano.Ali me itigil nung ika mu bisa uli mu pamu ning giya a ini, lalu na nung atyu ka king very-low-protein diet. Dalan me ing reseta, planu king pamangan, at reng label ning supplement king menyulat ning reseta, at kutnan me nung akma ya pa kekang ing planu. Ing “Hold” king titulu buri nang sabyan: ali ka mumpisa nung alang planu.

What these tablets are meant to doAno ang layunin ng mga tabletang itoUnsa ang katuyoan niini nga mga tabletaNanu ing kaplanan dareng tableta a reti

Protein in food is made of small building blocks called amino acids. Your body keeps the ones it needs to repair muscle and organs. What is left over is broken down, and its nitrogen becomes urea, a waste product the kidneys must remove. When the kidneys are weak, urea and other wastes from protein build up.Ang protina sa pagkain ay binubuo ng maliliit na bahagi na tinatawag na amino acid. Itinatabi ng katawan ang mga kailangan nito para ayusin ang kalamnan at mga organ. Ang sobra ay dinudurog, at ang nitrogen nito ay nagiging urea, isang dumi na kailangang ilabas ng bato. Kapag mahina ang bato, naiipon ang urea at iba pang dumi mula sa protina.Ang protina sa pagkaon gilangkob sa gagmay nga bahin nga gitawag og amino acid. Gitipigan sa lawas ang mga kinahanglanon niini aron ayohon ang kaunoran ug mga organ. Ang sobra gidugmok, ug ang nitrogen niini mahimong urea, usa ka hugaw nga kinahanglang ipagawas sa kidney. Kung huyang ang kidney, matipon ang urea ug uban pang hugaw gikan sa protina.Ing protina king pamangan bubuuan da ning malating bage a aus dang amino acid. Itatabi ning katawan ing kailangan na bang ayusan ing laman at reng organ. Ing labis gugurlan de, at ing nitrogen na magbalang urea, metung a dinat a kailangan nang ilwal ning batu. Nung malati ing batu, mipun ya ing urea at aliwa pang dinat ibat king protina.

Ketoanalogues are close relatives of some essential amino acids, but most of their parts arrive without the nitrogen. Inside the body they can pick up nitrogen that is already there and become usable amino acids. That is why, only when food protein is carefully lowered, they can help supply what the body needs while less waste is made.Ang ketoanalogue ay malapit na kamag-anak ng ilang essential amino acid, pero karamihan sa mga bahagi nito ay dumarating nang walang nitrogen. Sa loob ng katawan, nakakakuha ito ng nitrogen na naroon na at nagiging magagamit na amino acid. Kaya, kapag maingat lamang na ibinaba ang protina sa pagkain, nakakatulong ito na maibigay ang kailangan ng katawan habang mas kaunting dumi ang nagagawa.Ang ketoanalogue suod nga paryente sa pipila ka essential amino acid, apan kadaghanan sa mga bahin niini moabot nga walay nitrogen. Sulod sa lawas, makakuha kini og nitrogen nga anaa na ug mahimong magamit nga amino acid. Mao nga, kung maampingon lang nga gipaubos ang protina sa pagkaon, makatabang kini paghatag sa kinahanglan sa lawas samtang mas gamay nga hugaw ang mahimo.Ing ketoanalogue malapit a kamaganak da ning sablang essential amino acid, oneng ing kayabakan kareng bage na datang alang nitrogen. King lub ning katawan, makakua yang nitrogen a atyu na at magbalang magamit a amino acid. Anya, nung maingat mu bisang pababan ing protina king pamangan, makasaup ya bang ibie ing kailangan ning katawan kabang kakaunti ing dinat a mayayari.

Four puzzle pieces fitting together under the title One program, not one pill: a written food plan, enough energy shown as a rice bowl and banana, a plain tablet box, and a follow-up calendar with a stethoscope; a faded tablet piece on its own is labeled tablet alone equals incomplete.

Ketoanalogues work only as one piece of a program: a written food plan, enough energy, the tablets, and follow-up. The tablet alone is an incomplete puzzle.Gumagana lamang ang ketoanalogue bilang isang bahagi ng programa: nakasulat na plano sa pagkain, sapat na enerhiya, ang tableta, at follow-up. Kulang na puzzle ang tableta lang.Molihok lang ang ketoanalogue isip usa ka bahin sa programa: sinulat nga plano sa pagkaon, igo nga enerhiya, ang tableta, ug follow-up. Kulang nga puzzle ang tableta ra.Gumana ya mu ing ketoanalogue bilang metung a bage ning programa: misulat a planu king pamangan, sapat a enerhiya, ing tableta, at follow-up. Kulang a puzzle ing tableta mu bisa.

🔍

Not the same as theseHindi ito katulad ng mga itoDili kini parehas niiniE ya kapareu dareni

Ketoanalogues are not ketone drinks, a “keto” diet, creatine, or ordinary protein powder. The names sound alike; the purpose is opposite. A ketogenic diet is usually high in fat and often in protein; protein powder adds protein; ketoanalogues are meant for a diet that lowers protein under supervision.Ang ketoanalogue ay hindi ketone drink, “keto” diet, creatine, o karaniwang protein powder. Magkatunog ang pangalan; magkasalungat ang layunin. Ang ketogenic diet ay kadalasang mataas sa taba at madalas sa protina; nagdadagdag ng protina ang protein powder; ang ketoanalogue ay para sa diyetang nagbababa ng protina nang may gabay.Ang ketoanalogue dili ketone drink, “keto” diet, creatine, o ordinaryong protein powder. Parehas ang tingog sa ngalan; supak ang katuyoan. Ang ketogenic diet kasagaran taas sa tambok ug kanunay sa protina; nagdugang og protina ang protein powder; ang ketoanalogue para sa diyeta nga nagpaubos sa protina nga adunay giya.Ing ketoanalogue e ketone drink, “keto” diet, creatine, o karaniwang protein powder. Magkatunug la ing lagyu; magkasalungat la ing kaplanan. Ing ketogenic diet karaniwang matas king taba at malagad king protina; magdagdag protina ing protein powder; ing ketoanalogue para king diyeta a magpababa king protina a atin gabay.

The tablets do not cancel extra proteinHindi binubura ng tableta ang dagdag na protinaDili papason sa tableta ang dugang nga protinaE ne buburan ning tableta ing dagdag a protina

Some people hear “kidney tablets” and think the tablets now protect them, so they add a bigger serving of meat, an extra egg, or a protein shake “for strength.” This is an understandable mistake, and nobody has measured how often it happens. But it works against the plan: the tablets were meant for a diet with less protein, not more.May mga taong nakakarinig ng “tableta para sa bato” at iniisip na pinoprotektahan na sila nito, kaya nagdadagdag sila ng mas malaking serving ng karne, dagdag na itlog, o protein shake “para lumakas.” Naiintindihang pagkakamali ito, at wala pang sumukat kung gaano ito kadalas. Pero salungat ito sa plano: ang tableta ay para sa diyetang may mas kaunting protina, hindi mas marami.Adunay mga tawo nga makadungog og “tableta para sa kidney” ug maghunahuna nga gipanalipdan na sila niini, mao nga nagdugang sila og mas dako nga serving sa karne, dugang nga itlog, o protein shake “para mokusog.” Masabtan kini nga sayop, ug wala pay nakasukod kung unsa kini kadalas. Apan supak kini sa plano: ang tableta para sa diyeta nga mas gamay og protina, dili mas daghan.Atin taung makarinig “tableta para king batu” at isipan dang protektadu na la, anya magdagdag lang mas maragul a serving ning karni, dagdag a ebun, o protein shake “bang kumusug.” Maintindian ya ing mali a ini, at ala pang sinukat nung makanyang dalas ya. Oneng salungat ya king planu: ing tableta para king diyeta a mas kaunti ing protina, e mas dakal.

A worked example (hypothetical)Halimbawang kuwenta (hypothetical)Pananglitan nga kuwenta (hypothetical)Alimbawang kuwenta (hypothetical)

Food protein your clinician already prescribedProtina sa pagkain na nireseta na ng iyong doktorProtina sa pagkaon nga gireseta na sa imong doktorProtina king pamangan a meresetang na ning doktor mu48 g/day
Protein from meals (rice, fish, vegetables, snacks)Protina mula sa mga kain (kanin, isda, gulay, meryenda)Protina gikan sa mga kan-on (kan-on, isda, utanon, meryenda)Protina ibat kareng pamangan (nasi, asan, gule, meryenda)48 g
+ One protein shake (label: 25 g per serving × 1)+ Isang protein shake (label: 25 g bawat serving × 1)+ Usa ka protein shake (label: 25 g matag serving × 1)+ Metung a protein shake (label: 25 g king balang serving × 1)25 g
Total from food and drinksKabuuan mula sa pagkain at inuminKinatibuk-an gikan sa pagkaon ug ilimnonKabuuan ibat king pamangan at inumin73 g/day
Above the prescribed amountLampas sa niresetaLabaw sa giresetaLampas king meresetang+25 g (+52.1%)

Arithmetic only. 52.1% more protein than the plan is not 52.1% more kidney risk, and it does not tell you what to change. Bring the shake label to your kidney team.Kuwenta lamang. Ang 52.1% na dagdag na protina sa plano ay hindi 52.1% na dagdag na panganib sa bato, at hindi nito sinasabi kung ano ang babaguhin. Dalhin ang label ng shake sa iyong kidney team.Kuwenta lang. Ang 52.1% nga dugang nga protina sa plano dili 52.1% nga dugang nga peligro sa kidney, ug dili kini mosulti kung unsa ang usbon. Dad-a ang label sa shake ngadto sa imong kidney team.Kuwenta mu bisa. Ing 52.1% a dagdag a protina king planu e 52.1% a dagdag a panganib king batu, at e ne sasabyan nung nanu ing gulisan. Dalan me ing label ning shake king kidney team mu.

Kitchen counter example labeled daily totals: a plate of rice, vegetables and fish tagged daily meals 48 grams, a hand holding a plain shake can whose magnified label reads protein 25 grams per serving, and a tally card adding 48 and 25 to a total of 73 grams, 25 grams above the 48-gram plan, with a note that tablets are counted separately.

Count protein from everything you eat and drink — including shakes, milk drinks, and “diabetes” or “recovery” products. The tablets are counted separately by your prescriber.Bilangin ang protina mula sa lahat ng kinakain at iniinom mo — kasama ang shake, inuming gatas, at mga produktong “pang-diabetes” o “pang-recovery.” Hiwalay na binibilang ng nagreseta ang tableta.Ihapa ang protina gikan sa tanan nimong gikaon ug giinom — lakip ang shake, ilimnong gatas, ug mga produkto nga “para sa diabetes” o “para sa recovery.” Lahi nga ihapon sa nagreseta ang tableta.Bilangan me ing protina ibat king eganagang pamangan at inumin mu — kayabe ing shake, inumin a gatas, at reng produktu a “para king diabetes” o “para king recovery.” Aliwa ing pamilang ning menyulat ning reseta king tableta.

Cutting food on your own is also riskyMapanganib din ang pagbabawas ng pagkain nang mag-isaPeligroso usab ang pagkunhod sa pagkaon nga ikaw raMapanganib ya murin ing pamanibawas king pamangan nung ika mu bisa

The other mistake is to remove meat, fish, eggs, milk, and beans all at once — and to eat less overall. When the body does not get enough energy, it burns its own muscle for fuel. That releases the same nitrogen waste the diet was trying to lower, and it leaves you weaker. A very-low-protein diet is only safe when someone checks that you are eating enough and keeping your weight and strength.Ang isa pang pagkakamali ay alisin nang sabay-sabay ang karne, isda, itlog, gatas, at beans — at kumain nang mas kaunti sa kabuuan. Kapag kulang ang enerhiya ng katawan, sinusunog nito ang sarili nitong kalamnan bilang gasolina. Naglalabas ito ng parehong nitrogen na dumi na sinusubukang ibaba ng diyeta, at nanghihina ka. Ligtas lang ang very-low-protein diet kapag may tumitingin na sapat ang kinakain mo at napapanatili ang iyong timbang at lakas.Ang laing sayop mao ang pagtangtang dungan sa karne, isda, itlog, gatas, ug beans — ug mokaon og mas gamay sa kinatibuk-an. Kung kulang ang enerhiya sa lawas, sunogon niini ang kaugalingong kaunoran isip gasolina. Mopagawas kini sa parehas nga nitrogen nga hugaw nga gisulayan pagpaubos sa diyeta, ug maluya ka. Luwas lang ang very-low-protein diet kung adunay mosusi nga igo ang imong gikaon ug mapadayon ang imong timbang ug kusog.Ing aliwang mali iya ing pamaliwa king karni, asan, ebun, gatas, at beans king metung a pamikatagun — at mangan mas kaunti king kabuuan. Nung kulang ing enerhiya ning katawan, puruan na ing sariling laman bilang gasolina. Ilwal na ing kaparehung nitrogen a dinat a pakasubukan nang pababan ning diyeta, at malati ka. Ligtas ya mu ing very-low-protein diet nung atin manlawe nung sapat ing pamangan mu at mapanatili ing timbang at kusug mu.

Error 1 — too muchPagkakamali 1 — sobraSayop 1 — sobraMali 1 — labis

Bigger meat portions or a daily protein shake because “the tablets protect me.”Mas malaking karne o araw-araw na protein shake dahil “pinoprotektahan ako ng tableta.”Mas dako nga karne o adlaw-adlaw nga protein shake tungod kay “gipanalipdan ko sa tableta.”Mas maragul a karni o aldo-aldo a protein shake uli ta “protektan na ku ning tableta.”

Error 2 — too littlePagkakamali 2 — kulangSayop 2 — kulangMali 2 — kulang

Skipping protein foods and meals without a plan, with weight and strength slipping.Paglaktaw sa protina at pagkain nang walang plano, habang bumababa ang timbang at lakas.Paglaktaw sa protina ug pagkaon nga walay plano, samtang mous-os ang timbang ug kusog.Paglaktaw king protina at pamangan nung alang planu, kabang mababa ing timbang at kusug.

Both errors can happen in the same home: small meals at the table, and a large protein drink between meals. That is why the visit should ask about every meal and every drink.Maaaring mangyari ang dalawa sa iisang bahay: maliliit na kain sa mesa, at malaking protein drink sa pagitan ng kain. Kaya dapat itanong sa pagbisita ang bawat kain at bawat inumin.Mahimong mahitabo ang duha sa usa ra ka balay: gagmay nga kan-on sa lamesa, ug dako nga protein drink taliwala sa kan-on. Mao nga kinahanglan pangutan-on sa bisita ang matag kan-on ug matag ilimnon.Malyaring mayari ing adwa king metung mung bale: malating pamangan king lamesa, at maragul a protein drink king pagitan ning pamangan. Anya dapat kutnan king pamamisita ing balang pamangan at balang inumin.

Three panels titled Two errors, one goal: too much shows fried pork, two eggs and a milky shake; planned plate shows rice, vegetables, fish, a checklist and a tablet box; too little shows a nearly empty plate, a glass of water and a loosened belt.

Two opposite errors, one goal: the planned plate in the middle, set with your kidney team and renal dietitian.Dalawang magkasalungat na pagkakamali, iisang layunin: ang planadong plato sa gitna, na itinakda kasama ang iyong kidney team at renal dietitian.Duha ka supak nga sayop, usa ka tumong: ang giplano nga plato sa tunga, gitakda uban sa imong kidney team ug renal dietitian.Adwang magkasalungat a mali, metung a kaplanan: ing meplanung plato king pengari, a metakda kayabe ning kidney team mu at renal dietitian.

Move your muscles so the protein has work to doGalawin ang kalamnan para may trabaho ang protinaLihoka ang kaunoran aron adunay trabaho ang protinaGamitan me ing laman ba atin obra ing protina

After a meal, your body decides where the amino acids go. Muscles that are used — standing up from a chair, climbing stairs, carrying groceries, lifting light weights — send a signal to build and repair, and they pull amino acids in. Muscles that rest all day send almost no signal, so more of those amino acids are broken down into urea instead. On a low-protein plan, where every gram should count, activity is how you make the protein you eat — and the building blocks the tablets help form — end up as muscle rather than waste.Pagkatapos kumain, ang katawan ang nagpapasya kung saan pupunta ang amino acid. Ang kalamnang ginagamit — pagtayo mula sa upuan, pag-akyat sa hagdan, pagbuhat ng pinamili, pagbuhat ng magaang pabigat — ay nagpapadala ng senyas na magtayo at mag-ayos, at hinihila nito ang amino acid. Ang kalamnang buong araw na nakapahinga ay halos walang senyas, kaya mas maraming amino acid ang nauuwi sa urea. Sa low-protein na plano, kung saan mahalaga ang bawat gramo, ang paggalaw ang paraan para ang protinang kinakain mo — at ang mga bahaging tinutulungang buuin ng tableta — ay maging kalamnan at hindi dumi.Human mokaon, ang lawas ang modesisyon kung asa moadto ang amino acid. Ang kaunoran nga gigamit — pagtindog gikan sa lingkuranan, pagsaka sa hagdan, pagbitbit sa gipamalit, pag-alsa og gaan nga pabug-at — mopadala og senyas nga motukod ug moayo, ug kuhaon niini ang amino acid. Ang kaunoran nga nagpahulay sa tibuok adlaw halos walay senyas, mao nga mas daghang amino acid ang mahimong urea. Sa low-protein nga plano, diin importante ang matag gramo, ang paglihok ang paagi aron ang protina nga imong gikaon — ug ang mga bahin nga gitabangan sa tableta paghimo — mahimong kaunoran ug dili hugaw.Kaibat mangan, ing katawan ing magdesisyun nung nokarin munta ing amino acid. Ing laman a gagamitan — pamikatalakad ibat king upuan, pamanik king agdan, pamuat kareng sinaliwa, pamuat magaan a pabigat — magpadala yang senyas bang magbuo at mag-ayus, at kuanan na ing amino acid. Ing laman a magpainawa king kabilan aldo, alos alang senyas, anya mas dakal a amino acid ing magbalang urea. King low-protein a planu, nung nu mayalaga ing balang gramu, ing pamagkilos ing paralan ba ing protina a pamangan mu — at ing bage a tutulungan ning tableta bang buuan — magbalang laman, e dinat.

In a small study of older adults with kidney disease on a low-protein diet, those who did strength training for 12 weeks kept their weight and gained muscle and strength, while those who did not lost strength. International kidney guidelines advise about 150 minutes a week of moderate activity, or whatever your heart and body can safely handle.Sa isang maliit na pag-aaral ng matatandang may sakit sa bato na nasa low-protein diet, ang mga nag-strength training nang 12 linggo ay napanatili ang timbang at nadagdagan ang kalamnan at lakas, habang humina ang mga hindi nag-ehersisyo. Pinapayo ng mga internasyonal na guideline sa bato ang mga 150 minuto kada linggo ng katamtamang aktibidad, o kung ano ang ligtas na kaya ng iyong puso at katawan.Sa usa ka gamay nga pagtuon sa mga tigulang nga adunay sakit sa kidney nga naa sa low-protein diet, ang mga nag-strength training sulod sa 12 ka semana nakapadayon sa ilang timbang ug nadugangan ang kaunoran ug kusog, samtang naluya ang wala. Gitambagan sa internasyonal nga mga guideline sa kidney ang mga 150 ka minuto matag semana sa kasarangang kalihokan, o unsay luwas nga makaya sa imong kasingkasing ug lawas.King metung a malating pamag-aral kareng matua a atin sakit king batu a atyu king low-protein diet, dareng menyampong strength training king 12 a dominggu, mepanatili ing timbang ra at miragdagan ing laman at kusug ra, kabang dareng ala, melati. Ipayu dareng internasyonal a guideline king batu ing malapit 150 minutu king dominggu a katamtamang aktibidad, o nanu ing ligtas a kaya ning pusu at katawan mu.

Figure titled Give the protein a job: amino acids from a plate of rice, vegetables and fish flow to an older Filipina doing a chair stand, labeled active muscle, supports building and repair; on the other side a seated resting figure is labeled less activity, where muscle turnover continues and more amino acids are broken down in the liver to urea that the kidneys clear.

Used muscles pull amino acids in to build and repair. Resting muscles leave more to be turned into urea, the waste your kidneys must clear.Hinihila ng ginagamit na kalamnan ang amino acid para magtayo at mag-ayos. Ang nakapahingang kalamnan ay nag-iiwan ng mas marami na nagiging urea, ang dumi na kailangang ilabas ng bato.Kuhaon sa gigamit nga kaunoran ang amino acid aron motukod ug moayo. Ang nagpahulay nga kaunoran mobilin og mas daghan nga mahimong urea, ang hugaw nga kinahanglang ipagawas sa kidney.Kuanan ning gagamitan a laman ing amino acid bang mamuo at mag-ayus. Ing laman a magpainawa iwanan na ing mas dakal a magbalang urea, ing dinat a kailangan nang ilwal ning batu.

💪

Simple ways to start (ask your team first)Simpleng paraan para magsimula (magtanong muna sa team)Simple nga paagi sa pagsugod (pangutana una sa team)Simpling paralan bang mumpisa (kutnan mu pa ing team)

Chair stands: stand up and sit down slowly, 8–10 times, holding a table if needed. Wall push-ups and light weights — water bottles count — 2 to 3 days a week. Walk 10 minutes after meals. Start low and build up week by week.Pagtayo mula sa upuan: tumayo at umupo nang dahan-dahan, 8–10 beses, humawak sa mesa kung kailangan. Wall push-up at magaang pabigat — puwede ang bote ng tubig — 2 hanggang 3 araw kada linggo. Maglakad nang 10 minuto pagkatapos kumain. Magsimula nang mababa at dagdagan linggo-linggo.Pagtindog gikan sa lingkuranan: tindog ug lingkod nga hinay, 8–10 ka higayon, kupti ang lamesa kung kinahanglan. Wall push-up ug gaan nga pabug-at — pwede ang botelya sa tubig — 2 hangtod 3 ka adlaw matag semana. Lakaw og 10 ka minuto human mokaon. Sugdi nga ubos ug dugangi matag semana.Pamikatalakad ibat king upuan: tumalakad at lumuklu king mabagal, 8–10 besis, kapitan ing lamesa nung kailangan. Wall push-up at magaan a pabigat — malyari ing bote ning danum — 2 anggang 3 aldo king dominggu. Lumakad 10 minutu kaibat mangan. Mumpisa king mababa at dagdagan dominggu-dominggu.

⚠️

Exercise is not a reason to add a protein shakeHindi dahilan ang ehersisyo para magdagdag ng protein shakeDili rason ang ehersisyo aron magdugang og protein shakeE dahilan ing ehersisyo bang magdagdag protein shake

If you start exercising, keep to your written food plan and ask your team whether anything should change. More activity often needs more energy (calories from rice, root crops, healthy oils) — not automatically more protein. Ask first if you have heart disease, chest pain on effort, dizziness, falls, or a recent hospital stay.Kung magsisimula kang mag-ehersisyo, sundin pa rin ang nakasulat na plano sa pagkain at itanong sa team kung may dapat baguhin. Ang mas maraming galaw ay madalas nangangailangan ng mas maraming enerhiya (calories mula sa kanin, lamang-ugat, malusog na mantika) — hindi awtomatikong mas maraming protina. Magtanong muna kung may sakit sa puso, pananakit ng dibdib kapag nagpapagod, pagkahilo, pagkakatumba, o bagong pagka-ospital.Kung magsugod ka og ehersisyo, sunda gihapon ang sinulat nga plano sa pagkaon ug pangutan-a ang team kung adunay angay usbon. Ang dugang nga paglihok kasagaran nagkinahanglan og dugang enerhiya (calories gikan sa kan-on, lagutmon, himsog nga mantika) — dili awtomatikong dugang protina. Pangutana una kung adunay sakit sa kasingkasing, sakit sa dughan inig kapoy, pagkalipong, pagkatumba, o bag-o lang na-ospital.Nung mumpisa kang mag-ehersisyo, tuparan me pa rin ing misulat a planu king pamangan at kutnan me ing team nung atin dapat gulisan. Ing mas dakal a pamagkilos karaniwan kailangan mas dakal a enerhiya (calories ibat king nasi, lamang-gamut, malusug a mantica) — e awtomatikung mas dakal a protina. Kumutang ka pa nung atin kang sakit king pusu, sakit king dibdib nung mapagal, pamakaliliu, pamagbagsak, o bayu kang me-ospital.

Four questions to answer before the first tabletApat na tanong bago ang unang tabletaUpat ka pangutana sa dili pa ang unang tabletaApat a kutang bayu ing mumunang tableta

Before starting — the four questionsBago magsimula — ang apat na tanongSa dili pa magsugod — ang upat ka pangutanaBayu mumpisa — ing apat a kutang
1
Is this the right situation and goal? What are we hoping the plan will do for me — fewer symptoms, more time before dialysis, something else?Ito ba ang tamang sitwasyon at layunin? Ano ang inaasahan nating gagawin ng plano para sa akin — mas kaunting sintomas, mas mahabang panahon bago mag-dialysis, o iba pa?Mao ba kini ang husto nga sitwasyon ug tumong? Unsa ang atong gilauman nga buhaton sa plano para nako — mas gamay nga sintomas, mas taas nga panahon sa dili pa mag-dialysis, o lain pa?Iti ya ba ing tamang sitwasyun at kaplanan? Nanu ing ating ipanaya tang agawa ning planu para kanaku — mas kaunting sintomas, mas malawig a panaun bayu ing dialysis, o aliwa pa?
2
What exactly should I eat? How many grams of protein from food and drinks, how many calories, and which body weight was used to set them?Ano talaga ang dapat kong kainin? Ilang gramo ng protina mula sa pagkain at inumin, ilang calories, at aling timbang ang ginamit para itakda ang mga ito?Unsa gyud ang angay nakong kaon-on? Pila ka gramo sa protina gikan sa pagkaon ug ilimnon, pila ka calories, ug unsang timbang ang gigamit sa pagtakda niini?Nanu talaga ing dapat kung pamangan? Pilan a gramu ning protina ibat king pamangan at inumin, pilan a calories, at nanung timbang ing gagamitan bang itakda la?
3
Can I and my household follow it? Without going hungry, losing weight, or spending money we do not have?Kaya ko ba at ng aking pamilya itong sundin? Nang hindi nagugutom, pumapayat, o gumagastos ng perang wala kami?Kaya ba nako ug sa akong panimalay kini sundon? Nga dili gutomon, mamiyuos, o mogasto og kuwarta nga wala namo?Kaya ku ba at ning pamilya ku ing tuparan ini? Nung e mangulasan, mamayat, o gumastus pera a ala kami?
4
Who will check on me? Which tests, how often, and whom do I call if I get sick, cannot eat, or cannot afford the plan?Sino ang titingin sa akin? Aling mga test, gaano kadalas, at sino ang tatawagan ko kung magkasakit ako, hindi makakain, o hindi kaya ang gastos?Kinsa ang mosusi nako? Unsang mga test, unsa kadalas, ug kinsa ang akong tawagan kung magmasakiton ko, dili makakaon, o dili makaya ang gasto?Ninu ing manlawe kanaku? Nanung test, makanyang dalas, at ninu ing tawagan ku nung magsakit ku, e makapangan, o e kaya ing gastus?
💡

“Hold” is about the tablets — not your other kidney careAng “Hold” ay para sa tableta — hindi sa iba mong gamutan sa batoAng “Hold” para sa tableta — dili sa uban nimong pag-atiman sa kidneyIng “Hold” para king tableta — e para king aliwa mung panulu king batu

Waiting for a nephrologist and renal dietitian should never pause your blood pressure, diabetes, or kidney-protecting medicines. Your current doctor stays in charge of your care until the handoff is done.Ang paghihintay sa nephrologist at renal dietitian ay hindi dapat magpatigil sa iyong gamot sa presyon, diabetes, o pamprotekta sa bato. Ang kasalukuyan mong doktor ang mananagot sa iyong pangangalaga hanggang matapos ang handoff.Ang paghulat sa nephrologist ug renal dietitian dili angay mohunong sa imong tambal sa presyon, diabetes, o pangpanalipod sa kidney. Ang imong kasamtangang doktor ang responsable sa imong pag-atiman hangtod mahuman ang handoff.Ing pamanaya king nephrologist at renal dietitian e dapat makapatigil king gamut mu king presyun, diabetes, o pamprotekta king batu. Ing doktor mu ngeni ing manyabat king pamanalaga keka anggang mayari ing handoff.

If you are already on ketoanaloguesKung umiinom ka na ng ketoanalogueKung nag-inom ka na og ketoanalogueNung mininum na kang ketoanalogue

Bring your prescription, your food plan, recent blood tests, and all supplement labels to your next appointment. Ask whether the tablets and the diet still fit your needs. If nobody has explained the food plan to you, contact your prescriber for clarification. Do not independently start a very-low-protein diet or change the number of tablets.Dalhin ang iyong reseta, plano sa pagkain, mga bagong blood test, at lahat ng label ng supplement sa susunod mong appointment. Itanong kung akma pa sa iyo ang tableta at ang diyeta. Kung walang nagpaliwanag sa iyo ng plano sa pagkain, kausapin ang nagreseta. Huwag magsimula nang mag-isa ng very-low-protein diet o baguhin ang dami ng tableta.Dad-a ang imong reseta, plano sa pagkaon, bag-ong blood test, ug tanang label sa supplement sa sunod nimong appointment. Pangutan-a kung haom pa kanimo ang tableta ug ang diyeta. Kung walay nagpasabot kanimo sa plano sa pagkaon, kontaka ang nagreseta. Ayaw pagsugod nga ikaw ra og very-low-protein diet o usba ang gidaghanon sa tableta.Dalan me ing reseta mu, planu king pamangan, bayung blood test, at eganagang label ning supplement king susunod mung appointment. Kutnan me nung akma la pa keka ing tableta at ing diyeta. Nung ala pang menyalaysay keka ning planu king pamangan, kausapan me ing menyulat ning reseta. Ali ka mumpisa nung ika mu bisa ning very-low-protein diet o gulisan ing dakal ning tableta.

📋

Tell your team early if…Sabihin agad sa iyong team kung…Isulti dayon sa imong team kung…Sabyan me agad king team mu nung…

you are eating much less, losing weight without trying, feeling weaker, vomiting or unable to eat, admitted to hospital, told your calcium is high, or cannot afford the tablets and the food plan together.mas kaunti na ang kinakain mo, pumapayat nang hindi sinasadya, nanghihina, nagsusuka o hindi makakain, na-admit sa ospital, sinabihang mataas ang calcium mo, o hindi kaya ang tableta at plano sa pagkain nang sabay.mas gamay na ang imong gikaon, mamiyuos nga wala tuyoa, nagkaluya, nagsuka o dili makakaon, na-admit sa ospital, giingnan nga taas ang imong calcium, o dili makaya ang tableta ug plano sa pagkaon nga dungan.mas kaunti na ing pamangan mu, mamayat nung e sinadya, malati, mumuta o e makapangan, me-admit king ospital, sinabyan dang matas ing calcium mu, o e kaya ing tableta at planu king pamangan king metung a pamikatagun.

🚨

Go to the emergency room now — do not wait for a nutrition appointment — if you have:Pumunta agad sa emergency room — huwag hintayin ang nutrition appointment — kung may:Adto dayon sa emergency room — ayaw hulata ang nutrition appointment — kung adunay:Munta ka agad king emergency room — ali mu antayan ing nutrition appointment — nung atin:

severe shortness of breath, chest pain, new confusion or unusual drowsiness, a seizure, fainting or collapse, a very slow, very fast, or irregular heartbeat, or little or no urine during an illness. Bring your medicine list and the tablet box. This guide cannot tell you the cause; emergency care can.matinding hirap sa paghinga, pananakit ng dibdib, bagong pagkalito o di-pangkaraniwang pag-aantok, kombulsyon, pagkahimatay o pagbagsak, napakabagal, napakabilis, o iregular na tibok ng puso, o kaunti o walang ihi habang may sakit. Dalhin ang listahan ng gamot at ang kahon ng tableta. Hindi masasabi ng gabay na ito ang sanhi; masasabi ito ng emergency care.grabe nga kalisod sa pagginhawa, sakit sa dughan, bag-ong kalibog o dili kasagaran nga pagkahinanok, kombulsyon, pagkaluya o pagkatumba, hinay kaayo, paspas kaayo, o dili regular nga pitik sa kasingkasing, o gamay o walay ihi samtang masakiton. Dad-a ang listahan sa tambal ug ang kahon sa tableta. Dili masulti niini nga giya ang hinungdan; masulti kini sa emergency care.makasakit a kasakitan king pamanyawa, sakit king dibdib, bayung pamakalitu o e karaniwang pamanuknang, kombulsyun, pamakaimatay o pamagbagsak, mabagal dalit, malagwa dalit, o e regular a pitik ning pusu, o kaunti o alang ihi kabang masakit. Dalan me ing listahan ning gamut at ing kahon ning tableta. E na asabi ning giya a ini ing sanhi; asabi na ning emergency care.

Helpful for some, in a supervised programNakakatulong sa ilan, sa isang programang may gabayMakatabang sa pipila, sa programa nga adunay giyaMakasaup kareng aliwa, king programa a atin gabay

In one careful study, selected adults who were well nourished and very good at following a vegetarian very-low-protein diet with ketoanalogues had fewer serious kidney events over about 15 months than those on a standard low-protein diet. In a later study of real clinic patients, simply prescribing the supplemented very-low-protein diet did not do better — partly because many people could not eat that way for long. A 2026 study in people with type 2 diabetes found a slower decline in one kidney blood test but not in another, so the results need confirming.Sa isang maingat na pag-aaral, ang piling mga adult na maayos ang nutrisyon at napakahusay sumunod sa vegetarian very-low-protein diet na may ketoanalogue ay nagkaroon ng mas kaunting malubhang pangyayari sa bato sa loob ng mga 15 buwan kaysa sa mga nasa karaniwang low-protein diet. Sa mas bagong pag-aaral ng totoong mga pasyente sa clinic, hindi naging mas mahusay ang basta pag-reseta ng supplemented very-low-protein diet — bahagya dahil maraming tao ang hindi nakakain nang ganoon nang matagal. Isang pag-aaral noong 2026 sa mga may type 2 diabetes ang nakakita ng mas mabagal na pagbaba sa isang kidney blood test pero hindi sa isa pa, kaya kailangan pang kumpirmahin.Sa usa ka maampingong pagtuon, ang pinili nga mga hamtong nga maayo ang nutrisyon ug maayo kaayo mosunod sa vegetarian very-low-protein diet nga adunay ketoanalogue nakabaton og mas gamay nga seryoso nga hitabo sa kidney sulod sa mga 15 ka bulan kaysa sa naa sa standard low-protein diet. Sa mas bag-ong pagtuon sa tinuod nga mga pasyente sa clinic, wala nahimong mas maayo ang basta pag-reseta sa supplemented very-low-protein diet — bahin tungod kay daghang tawo ang dili makakaon niana sulod sa dugay. Usa ka pagtuon sa 2026 sa mga adunay type 2 diabetes nakakita og mas hinay nga pagkunhod sa usa ka kidney blood test apan dili sa lain, mao nga kinahanglan pa kini kumpirmahon.King metung a maingat a pamag-aral, reng piling matua a mayap ing nutrisyon at mayap dalit tumupad king vegetarian very-low-protein diet a atin ketoanalogue, mekatagun lang mas kaunting malalang pangyayari king batu kilub ning 15 bulan kesa kareng atyu king karaniwang low-protein diet. King mas bayung pamag-aral kareng tutung pasyente king clinic, e mekapagmayap ing pamag-reseta mu ning supplemented very-low-protein diet — bage uli ta dakal a tau ing e makapangan makanyan king malawig. Metung a pamag-aral king 2026 kareng atin type 2 diabetes ing mekakit mas mabagal a pamababa king metung a kidney blood test oneng e king aliwa, anya kailangan pang kumpirman.

⚖️

The honest bottom lineAng tapat na buodAng matinud-anon nga sumadaIng tapat a buod

Some supervised programs have helped selected patients postpone dialysis. Results vary between studies. No study shows that taking the tablets without the dietary program prevents kidney failure, and none shows the tablets reverse CKD. A better creatinine number alone is not proof the kidneys healed — diet and muscle change that number too.Nakatulong ang ilang programang may gabay sa piling pasyente na maantala ang dialysis. Nag-iiba ang resulta sa bawat pag-aaral. Walang pag-aaral na nagpapakitang napipigilan ng tableta, kung walang programa sa pagkain, ang kidney failure, at walang nagpapakitang binabalik nito ang CKD. Ang mas magandang creatinine ay hindi patunay na gumaling ang bato — nababago rin ng diyeta at kalamnan ang numerong iyon.Nakatabang ang pipila ka programa nga adunay giya sa pinili nga pasyente nga maantala ang dialysis. Lahi-lahi ang resulta sa matag pagtuon. Walay pagtuon nga nagpakita nga mapugngan sa tableta, kung walay programa sa pagkaon, ang kidney failure, ug walay nagpakita nga ibalik niini ang CKD. Ang mas maayo nga creatinine dili pamatuod nga naayo ang kidney — mausab usab sa diyeta ug kaunoran kana nga numero.Mekasaup ing sablang programa a atin gabay kareng piling pasyente bang mabalam ing dialysis. Magkaiba ing resulta king balang pamag-aral. Alang pamag-aral a mamakit a apigilan ning tableta, nung alang programa king pamangan, ing kidney failure, at alang mamakit a ibalik na ing CKD. Ing mas mayap a creatinine e patunay a meayus ing batu — agulisan ya murin ning diyeta at laman ing numeru a ita.

Questions to bring to your appointmentMga tanong na dadalhin sa appointmentMga pangutana nga dad-on sa appointmentReng kutang a dalan king appointment

✅

Teach-back: say it in your own wordsTeach-back: sabihin sa sarili mong salitaTeach-back: isulti sa imong kaugalingong pulongTeach-back: sabyan me king sariling amanu mu

Before you leave, answer this out loud: “What, if anything, will I change about my portions or protein drinks after today?” If the answer is unclear to you or your family, ask again.Bago umalis, sagutin ito nang malakas: “Ano, kung mayroon, ang babaguhin ko sa aking serving o protein drink pagkatapos ngayon?” Kung hindi malinaw sa iyo o sa pamilya, magtanong muli.Sa dili pa mobiya, tubaga kini og kusog: “Unsa, kung aduna, ang akong usbon sa akong serving o protein drink human karon?” Kung dili klaro kanimo o sa pamilya, pangutana pag-usab.Bayu ka malako, sabatan me ini king makas a sabi: “Nanu, nung atin, ing gulisan ku king serving o protein drink ku kaibat ngeni?” Nung e malino keka o king pamilya, kumutang ka pasibayu.

Common questionsMga karaniwang tanongKasagarang mga pangutanaKaraniwang kutang

My heart doctor prescribed ketoanalogues. Is that wrong?Nireseta ng aking doktor sa puso ang ketoanalogue. Mali ba iyon?Gireseta sa akong doktor sa kasingkasing ang ketoanalogue. Sayop ba kana?Me-reseta ning doktor ku king pusu ing ketoanalogue. Mali ya ba ita?
Not necessarily. Many doctors care for people with CKD. The question is whether a food plan, a renal dietitian, and follow-up came with the prescription. If not, ask your doctor to coordinate a kidney and nutrition review — and keep taking your other medicines.Hindi naman. Maraming doktor ang nag-aalaga sa may CKD. Ang tanong ay kung may kasamang plano sa pagkain, renal dietitian, at follow-up ang reseta. Kung wala, hilingin sa iyong doktor na ayusin ang pagsusuri ng bato at nutrisyon — at ituloy ang iba mong gamot.Dili kinahanglan. Daghang doktor ang nag-atiman sa adunay CKD. Ang pangutana kung adunay kauban nga plano sa pagkaon, renal dietitian, ug follow-up ang reseta. Kung wala, hangyoa ang imong doktor nga ihan-ay ang pagsusi sa kidney ug nutrisyon — ug padayona ang uban nimong tambal.E kailangan. Dakal a doktor ing malage kareng atin CKD. Ing kutang iya nung atin kayabeng planu king pamangan, renal dietitian, at follow-up ing reseta. Nung ala, aliwan mu ing doktor mu bang ayusan ing pamanyalese king batu at nutrisyon — at ituloy me ing aliwa mung gamut.
Can I just take the tablets and eat normally?Puwede bang inumin ko lang ang tableta at kumain nang normal?Mahimo ba nga inumon ra nako ang tableta ug mokaon nga normal?Malyari ba nung inuman ke mu ing tableta at mangan ku king normal?
That is the combination with the least support. The studies tested tablets together with a lowered-protein diet. Your team may decide you need neither the tablets nor a very-low-protein diet — many people with CKD do well with a moderate protein plan.Iyan ang kombinasyong may pinakakaunting suporta. Sinubok ng mga pag-aaral ang tableta kasama ang diyetang mababa sa protina. Maaaring magpasya ang iyong team na hindi mo kailangan ang tableta o ang very-low-protein diet — maraming may CKD ang maayos sa katamtamang plano sa protina.Kana ang kombinasyon nga labing gamay og suporta. Gisulayan sa mga pagtuon ang tableta uban sa diyeta nga ubos sa protina. Mahimong modesisyon ang imong team nga dili nimo kinahanglan ang tableta o ang very-low-protein diet — daghang adunay CKD ang maayo sa kasarangang plano sa protina.Ita ing kombinasyun a pekakaunti ing suporta. Sinubuk dareng pamag-aral ing tableta kayabe ing diyeta a mababa king protina. Malyaring pasyaran ning team mu a e mu kailangan ing tableta o ing very-low-protein diet — dakal a atin CKD ing mayap king katamtamang planu king protina.
I bought ketoanalogues at the pharmacy without a prescription. Is that a problem?Bumili ako ng ketoanalogue sa botika nang walang reseta. Problema ba iyon?Nipalit ko og ketoanalogue sa botika nga walay reseta. Problema ba kana?Sinaliwa ku ketoanalogue king botika a alang reseta. Problema ya ba ita?
In the Philippines, some brands can be sold without a prescription. That makes the product easier to get, not safer to use alone. Do not stop suddenly if you have been taking them for a while — bring the box to your doctor, ask for a kidney and nutrition review, and let the team decide whether the tablets fit a written food plan. Show the box, because brands differ, and many contain calcium.Sa Pilipinas, may mga brand na puwedeng bilhin nang walang reseta. Ginagawa nitong mas madaling makuha ang produkto, hindi mas ligtas gamitin nang mag-isa. Huwag biglang itigil kung matagal mo na itong iniinom — dalhin ang kahon sa iyong doktor, humiling ng pagsusuri sa bato at nutrisyon, at hayaan ang team na magpasya kung akma ang tableta sa nakasulat na plano sa pagkain. Ipakita ang kahon, dahil magkakaiba ang brand at marami ang may calcium.Sa Pilipinas, adunay mga brand nga mapalit nga walay reseta. Kini naghimo sa produkto nga mas sayon makuha, dili mas luwas gamiton nga ikaw ra. Ayaw kalit hunonga kung dugay na nimo kini giinom — dad-a ang kahon sa imong doktor, pangayo og pagsusi sa kidney ug nutrisyon, ug pasagdi ang team nga modesisyon kung haom ang tableta sa sinulat nga plano sa pagkaon. Ipakita ang kahon, kay lahi-lahi ang brand ug daghan ang adunay calcium.King Pilipinas, atin brand a malyaring saliwan nung alang reseta. Pagawan na iting mas malagua akuan ing produktu, e mas ligtas gamitan nung ika mu bisa. Ali mu biglang itigil nung malwat mu nang inuminum — dalan me ing kahon king doktor mu, aliwan me ing pamanyalese king batu at nutrisyon, at pabayan me ing team a mamasya nung akma ya ing tableta king misulat a planu king pamangan. Ipakit me ing kahon, uli ta magkaiba la reng brand at dakal ing atin calcium.
Is plant protein “free”?“Libre” ba ang protina mula sa halaman?“Libre” ba ang protina gikan sa tanom?“Libre” ya ba ing protina ibat king tanaman?
No. Beans, tofu, and grains are often good choices, and plant-forward eating has benefits — but their protein still counts toward your daily total.Hindi. Kadalasang magandang pagpipilian ang beans, tokwa, at butil, at may benepisyo ang pagkaing mas maraming halaman — pero kasama pa rin ang protina nila sa iyong kabuuan sa isang araw.Dili. Kasagaran maayong pilian ang beans, tokwa, ug lugas, ug adunay benepisyo ang pagkaon nga daghang tanom — apan apil gihapon ang ilang protina sa imong kinatibuk-an sa usa ka adlaw.Ali. Karaniwang mayap a pipilian ing beans, tokwa, at butil, at atin benepisyu ing pamangan a dakal a tanaman — oneng kayabe ya pa rin ing protina ra king kabuuan mu king metung aldo.
Do I need to stop my protein shake today?Kailangan ko bang itigil ang protein shake ngayon?Kinahanglan ba nakong hunongon ang protein shake karon?Kailangan ke ba itigil ing protein shake ngeni?
Do not make a sudden change on your own — especially if you are eating poorly, since the shake may be part of your energy. Bring the label to your team; they may swap it for a lower-protein, energy-rich option or adjust your meals.Huwag gumawa ng biglaang pagbabago nang mag-isa — lalo na kung mahina kang kumain, dahil maaaring bahagi ng iyong enerhiya ang shake. Dalhin ang label sa iyong team; maaari nila itong palitan ng mas mababa sa protina at mayaman sa enerhiya, o ayusin ang iyong mga kain.Ayaw paghimo og kalit nga kausaban nga ikaw ra — labi na kung luya ka mokaon, kay mahimong bahin sa imong enerhiya ang shake. Dad-a ang label sa imong team; mahimo nila kini ilisan og mas ubos sa protina ug dato sa enerhiya, o ayohon ang imong mga kan-on.Ali kang gumawang biglang pamagbayu nung ika mu bisa — lalu na nung malati kang mangan, uli ta malyaring bage ning enerhiya mu ing shake. Dalan me ing label king team mu; malyari dang alilan ning mas mababa king protina at mayaman king enerhiya, o ayusan ing pamangan mu.

The problem is the missing plan, not the prescriber

Ketoanalogues (KA) are an adjunct, not a stand-alone kidney drug. Every positive trial delivered them inside a dietitian-supervised low-protein diet (LPD) or very-low-protein diet (VLPD) with adequate energy, in selected adults with non-dialysis chronic kidney disease (CKD). The clinical risk this guide addresses arises when the tablet is started without a written food-protein and energy prescription, without an assessment of what the patient actually eats, and without a named person who will review response, nutrition, and calcium.

The author's motivating observation is ketoanalogue initiation in cardiology, pulmonology, and general internal medicine clinics without that scaffold. It is an observation from practice, not a measured prevalence, and it is not an argument about specialty. A nephrologist who writes the tablet without a food plan creates the same problem. The proposed pathway is coordination: the referring clinician, nephrologist, renal dietitian, pharmacist, patient, and the household member who buys and cooks the food share one plan.

“Hold” means defer an unsupervised new start. It never means instructing a current user to stop, least of all a patient already on a supervised supplemented VLPD, where withdrawing the supplement while the diet continues removes essential amino-acid provision. Nor does it pause any other kidney-protective treatment while a referral is pending; the current clinician remains responsible for interim care.

🎯

Message to preserve

Before prescribing ketoanalogues, establish the nutritional prescription and the follow-up plan. Ask what the patient actually eats, including protein drinks and supplements, and give the protein a job with a physical activity plan. Coordinate nephrology and renal nutrition care so the patient understands both the treatment goal and the food plan.

Scope: adults with non-dialysis CKD. Dialysis, kidney transplantation, pregnancy, children, and acute illness need separate assessment and are outside this initiation pathway.

Why the diet carries the effect and the tablet supports it

Normal nitrogen handling

Dietary protein is hydrolyzed to amino acids. Those not incorporated into protein are deaminated; the amino nitrogen is converted to urea in the liver and excreted by the kidney. Protein catabolism also generates fixed acid (from sulfur-containing amino acids), phosphate, and several gut-derived uremic toxin precursors. Each gram of nitrogen corresponds to roughly 6.25 g of protein. Established physiology

What CKD breaks

As filtration falls, urea, hydrogen ion, and phosphate are cleared less completely, so their concentrations rise with any given protein load. Protein intake also acutely raises single-nephron filtration: amino acids increase proximal sodium reabsorption, which reduces macula densa sodium delivery and dilates the afferent arteriole through tubuloglomerular feedback. Chronic hyperfiltration of the remaining nephrons is the mechanistic argument for avoiding high intake in progressive CKD; it is why Kidney Disease: Improving Global Outcomes (KDIGO) advises against more than 1.3 g/kg/day. Established physiology Mechanistic link to progression

What the tablet adds

The reference product combines calcium salts of the keto- or hydroxy-analogues of isoleucine, leucine, phenylalanine, valine, and methionine with five amino acids (lysine, threonine, tryptophan, histidine, tyrosine). The analogues can accept an amino group by transamination from non-essential amino acids and so become the corresponding essential amino acid without new nitrogen entering the body. When dietary protein is very low, this supplies essential amino acids while urea generation falls. The tablet is not nitrogen-free: one listed formulation carries 36 mg of nitrogen and 50 mg (1.25 mmol) of elemental calcium per tablet. Established biochemistry

Nitrogen in 12 tablets12 × 36 mg = 432 mg N ≈ 2.7 g protein-equivalent
Nitrogen in one 25 g protein shake25 g ÷ 6.25 ≈ 4.0 g N
Approximate amino-group capacity of 12 tablets≈ 30 mmol analogue ≈ 0.4 g N
Order-of-magnitude arithmetic from listed composition (analogue salt masses ÷ approximate molar mass). Even if every analogue molecule accepted one amino group — which the body does not guarantee — the tablets could take up roughly a tenth of the nitrogen in a single 25 g shake. This is a mechanistic illustration, not a measured clinical effect.

This arithmetic is the core of the guide. The analogues spare nitrogen only when there is little to spare. Added to an unrestricted or escalating intake, excess amino acids are still deaminated and the urea, acid, and phosphate load is still delivered to the kidney. The tablet cannot absorb a protein shake. Evidence-supported inference

Why energy matters as much as protein

When energy intake is inadequate, amino acids — dietary and muscle-derived — are oxidized for fuel. Muscle catabolism then releases nitrogen, potassium, and acid, the very loads the diet set out to reduce, while lean mass falls. The Kidney Disease Outcomes Quality Initiative (KDOQI) nutrition guideline therefore pairs any protein restriction with 25–35 kcal/kg/day, individualized. A protein-restricted patient who is also eating too little is exposed to wasting without the intended metabolic benefit. Established physiology

Mechanism figure titled Nitrogen reuse needs a nutrition plan: dietary protein is digested to amino acids, the liver makes urea, and CKD reduces clearance; an inset shows transamination, where an amino donor gives its amino group to a ketoanalogue to form an essential amino acid used for protein synthesis, noted as a qualitative mechanism with no fixed capacity established, and a shake labeled extra protein still adds nitrogen; a bottom row adds food plan, enough energy, ketoanalogues and follow-up.

Ketoanalogues accept amino groups by transamination and can help reuse nitrogen only when dietary protein is low and energy is adequate. The capacity is not a fixed, measured amount, and extra protein still adds nitrogen.Ketoanalogues accept amino groups by transamination and can help reuse nitrogen only when dietary protein is low and energy is adequate. The capacity is not a fixed, measured amount, and extra protein still adds nitrogen.Ketoanalogues accept amino groups by transamination and can help reuse nitrogen only when dietary protein is low and energy is adequate. The capacity is not a fixed, measured amount, and extra protein still adds nitrogen.Ketoanalogues accept amino groups by transamination and can help reuse nitrogen only when dietary protein is low and energy is adequate. The capacity is not a fixed, measured amount, and extra protein still adds nitrogen.

CKD
Chronic kidney disease

Give the amino acids a destination: the anabolic stimulus

Nitrogen sparing has a second half that diet prescriptions often leave out. Whether an amino acid — dietary, or newly formed from an analogue by transamination — is incorporated into muscle protein or oxidized to urea depends on the anabolic signal at the time. Amino-acid availability (leucine in particular) and mechanical loading converge on muscle protein synthesis, and resistance exercise increases the muscle's sensitivity to amino acids for many hours afterward. An inactive patient with CKD is the opposite case: metabolic acidosis, inflammation, and insulin resistance blunt the anabolic response, so a larger share of the amino-acid pool is deaminated and appears as urea. Physical activity is therefore the physiologic “sink” that turns nitrogen sparing into nitrogen retention. Established physiology

The evidence is small but direct. In a 12-week randomized controlled trial (RCT), 26 older adults with moderate CKD stabilized on a 0.6 g/kg/day diet were assigned to resistance training or none. Training increased total body potassium (a marker of cell mass) by about 4% and type I and II muscle-fiber area by about 24% and 22%, reduced leucine oxidation, improved prealbumin, and maintained body weight; strength rose 32% with training and fell 13% without it. The trial did not use ketoanalogues, so extending it to a supplemented VLPD is an inference — but a physiologically coherent one. Small RCT Inference to KA

Acidosis matters for the supplement itself. Acidosis activates branched-chain keto-acid dehydrogenase, the enzyme that irreversibly oxidizes the keto-acids of leucine, isoleucine, and valine — three of the five analogues in the tablet. Correcting persistent metabolic acidosis, as the 2026 Nutrients review lists among the conditions for effectiveness, plausibly preserves those analogues for transamination instead of oxidation. Established enzymology Mechanistic hypothesis for KA

Mechanism figure titled Activity supports muscle protein synthesis: a man doing a chair stand provides mechanical loading; dietary amino acids and ketoanalogue-derived amino acids travel in the bloodstream to muscle, where amino acids, leucine and loading drive muscle protein synthesis; acidosis, inflammation, inactivity and insulin resistance impair the anabolic response and increase amino-acid breakdown to urea and branched-chain ketoacid oxidation, labeled experimental evidence.

Activity gives amino acids a destination. Loading plus amino-acid supply drives muscle protein synthesis; acidosis, inflammation, and inactivity divert them to oxidation and urea.Activity gives amino acids a destination. Loading plus amino-acid supply drives muscle protein synthesis; acidosis, inflammation, and inactivity divert them to oxidation and urea.Activity gives amino acids a destination. Loading plus amino-acid supply drives muscle protein synthesis; acidosis, inflammation, and inactivity divert them to oxidation and urea.Activity gives amino acids a destination. Loading plus amino-acid supply drives muscle protein synthesis; acidosis, inflammation, and inactivity divert them to oxidation and urea.

Kidney Disease: Improving Global Outcomes recommends advising people with CKD to undertake moderate-intensity physical activity for a cumulative 150 minutes a week, or to a level compatible with cardiovascular and physical tolerance (1D). For a patient on a protein-restricted plan, the practical prescription adds resistance work on two or three days a week, started low and progressed, with fall-risk and cardiac screening where relevant. More activity raises energy needs; it is not, by itself, a reason to raise protein, and any change belongs to the dietitian's written plan.

Interpreting the kidney numbers afterward

Lower meat intake reduces dietary creatine and creatinine, and reduced muscle mass lowers creatinine generation. Serum creatinine can therefore fall, and creatinine-based estimated glomerular filtration rate (eGFR) rise, without any change in true filtration. Cystatin C is less diet-dependent but is affected by inflammation, corticosteroids, thyroid status, and adiposity. The 2026 diabetes trial below found divergent cystatin C and creatinine trajectories under the same intervention. Read a trend of both markers alongside albuminuria, weight interpreted with fluid status, and clinical condition; an improved creatinine is not proof of CKD regression.

Four distinct harms — keep them separate

Potential harm arises when the prescription is disconnected from what the patient actually eats, their nutritional needs, and follow-up. The four mechanisms below differ in their evidence and should not be blurred into one warning.

What can go wrong, and how sure we are
A
Documented treatment risks. Calcium-containing formulations can cause hypercalcemia; product information lists hypercalcemia and disordered amino-acid metabolism as contraindications, phenylalanine content in phenylketonuria, and chelation interactions (separate tetracyclines, fluoroquinolones, iron, and other calcium-binding drugs). Restrictive diets require nutritional assessment. No trial establishes that tablets added to an unrestricted diet deliver the outcomes of a supervised dietary program. Product information · trial design
B
Plausible behavioral harm — counsel for it. A patient may read “kidney tablets” as permission to enlarge meat portions, add a protein shake, or combine supplements. No study has measured how often prescribing triggers this or quantified the kidney consequence. Ask directly at every visit. Hypothesis · counseling target
C
The opposite error. Indiscriminate removal of meat, fish, eggs, dairy, and legumes with a fall in total energy. In a 2026 retrospective cohort of patients with CKD and heart failure on a supplemented VLPD with dietitian involvement, weight fell by a median of about 4% and chart-recorded signs of nutritional deterioration appeared in a third. Both errors can coexist in one household: small meals and a large protein drink. Observational signal
D
Opportunity cost. Tablet burden (often 12 or more a day), tests, visits, and food changes consume household money and attention. Present this as a decision to discuss; it is not a measured cause of non-adherence or a proven cost-effectiveness result. Discussion point
✍️

Language to avoid

“Ketoanalogues damage the kidneys.” “Non-nephrologists cause CKD progression.” “These pills reverse CKD.” “Studies show patients eat more protein after starting ketoanalogues.” None is supported by evidence.

Three-column clinician figure titled Two errors around one prescription: protein escalation with a 25 gram per serving shake, steak and a supplement tub labeled plausible, not measured, ask every visit; a documented plan checklist of protein, energy, reference weight and basis, renal dietitian and monitoring owner; and unsupervised restriction with a small plate, scale with a fluid drop, falling trend and grip device labeled potential nutrition harm, assess intake and fluid status.

Protein escalation is a plausible but unmeasured risk; unsupervised restriction is a potential nutrition harm to check with intake and fluid status. The documented plan sits between them.Protein escalation is a plausible but unmeasured risk; unsupervised restriction is a potential nutrition harm to check with intake and fluid status. The documented plan sits between them.Protein escalation is a plausible but unmeasured risk; unsupervised restriction is a potential nutrition harm to check with intake and fluid status. The documented plan sits between them.Protein escalation is a plausible but unmeasured risk; unsupervised restriction is a potential nutrition harm to check with intake and fluid status. The documented plan sits between them.

What the guidelines actually say — kept separate

KDIGO, KDOQI, the American Diabetes Association (ADA), and the Asian Pacific Society of Nephrology (APSN) diabetic kidney disease (DKD) guideline address different populations and use different grading systems. Their targets should not be blended into a single “consensus range,” and their grades should not be converted between systems.

SourcePopulationPositionStrength
KDIGO 2024 CKDAdults, CKD G3–G5, not on dialysisMaintain protein about 0.8 g/kg/day. Avoid more than 1.3 g/kg/day in those at risk of progression. In adults who are willing and able and at risk of kidney failure, consider, under close supervision, a VLPD of 0.3–0.4 g/kg/day supplemented with essential amino acids or ketoacid analogues (up to 0.6 g/kg/day). Do not prescribe low- or very-low-protein diets in metabolically unstable people. Separately, advise moderate-intensity physical activity for a cumulative 150 minutes a week, or as tolerated.0.8 g/kg/day: suggestion, 2C. Upper limit and supplemented VLPD: practice points (ungraded). Physical activity: 1D
KDOQI 2020 NutritionMetabolically stable CKD G3–G5, not on dialysisProtein restriction under close clinical supervision: without diabetes, LPD 0.55–0.60 g/kg/day or VLPD 0.28–0.43 g/kg/day with ketoacid/amino-acid analogues; with diabetes, 0.6–0.8 g/kg/day. Energy 25–35 kcal/kg/day, individualized.Without diabetes: 1A for reducing kidney failure or death; 2C for quality of life. With diabetes (0.6–0.8): OPINION
ADA Standards of Care 2026Diabetes with non-dialysis CKD G3 or higherProtein about 0.8 g/kg/day, as for the general population; routine reduction below that amount is not recommended. Older adults with diabetes: at least 0.8 g/kg/day to maintain lean mass and function.ADA evidence grading (see Section 11)
APSN 2025 DKD updateDiabetic kidney disease, Asia–PacificClinical Recommendation 3.3: “We suggest that people with diabetic kidney disease receive a protein intake of 0.8 g/kg/day, and that ketoanalogues not be given for the purpose of preservation of kidney function.” The work group cites conflicting data, cost, and limited availability. It does not address ketoanalogues used for other goals within a supervised program.2C

The difference is mainly between nutrition-led and outcome-led readings of the same small trial base: KDOQI weighted the dietary trials toward a restriction recommendation; KDIGO rated the certainty low and kept 0.8 g/kg/day as the default, moving supplemented VLPD into a supervised practice point. In diabetes, ADA and APSN both resist routine reduction below 0.8 g/kg/day. The 2026 diabetes trial is subsequent evidence; it has not, by itself, rewritten these guidelines.

⛔

Do not turn the numbers into a dosing rule

KDIGO's “up to 0.6 g/kg/day” describes the total of a supplemented regimen. It is not a food-protein target plus another 0.6, and it is not a tablet conversion factor. No guideline supports a patient-facing formula that converts weight into tablets without a food prescription.

What the trials can and cannot show

This is a targeted update (searched 11 November 2026), not a systematic review. Each randomized controlled trial (RCT) and cohort below keeps its own population, comparator, and endpoint. The supportive selected-patient trial sits beside the neutral pragmatic trial on purpose: both are true, and the difference between them is the lesson.

StudyDesign and populationComparisonResultReading
Garneata 2016Single-center RCT; 207 nondiabetic adults, eGFR <30, proteinuria <1 g/g, well nourished and compliant through a 3-month run-in; only about 14% of screened patients randomizedVegetarian VLPD 0.3 g/kg/day + KA (1 tablet/5 kg) vs conventional LPD 0.6 g/kg/day; 15 monthsKidney replacement therapy (KRT) or >50% eGFR fall: about 13% vs 42%; adjusted number needed to treat (NNT) 4.4 (ITT)Efficacy of a combined program in a highly selected population. Diet quantity, diet pattern, and supplement all differed. The endpoint is a composite, not dialysis alone.
ERIKA (Bellizzi 2022)Pragmatic multicenter RCT; 223 patients, CKD G4–G5, under regular nephrology care; 35% diabetesPrescribed supplemented VLPD 0.35 vs LPD 0.60 g/kg ideal body weight/day; median 74.2 monthsRenal death (dialysis or death before dialysis): HR 1.17 (95% CI 0.88–1.57); achieved intake 0.60 vs 0.83 g/kg/day; no nutritional deteriorationNo added benefit from prescribing the strategy when adherence is real-world. Neither proves universal ineffectiveness nor supports unsupervised tablets.
Modification of Diet in Renal Disease (MDRD) Study B follow-up (Menon 2009)Long-term follow-up of 255 randomized, mostly stage 4 nondiabetic participantsVLPD 0.28 g/kg/day + keto/amino-acid mixture vs LPD 0.58 g/kg/dayKidney failure HR 0.83 (0.62–1.12); death HR 1.92 (1.15–3.20)Diet not measured after the trial. A historical safety signal from diet assignment, not proof that current tablets cause death. Reinforces nutrition follow-up.
Chen 2024 meta-analysis16 RCTs, 1,344 participants, CKD 3–5, median 13 monthsKA + LPD/VLPD vs LPD aloneHigher GFR; lower urea and phosphorus; higher calcium; marginally lower end-stage kidney disease (ESKD) risk without diabetes; no mortality differencePromising pooled signals, short duration, heterogeneous diets. Contains Garneata — not independent confirmation. “No nutritional difference” does not prove absence of malnutrition.
Chen 2021 (Taiwan)Nationwide insurance-database cohort; 15,782 adults with stage 5 diabetic kidney disease not on dialysis; 6.3% used ketoanaloguesUsers vs nonusers, landmark analysis with overlap weighting; 5 yearsAll-cause mortality adjusted hazard ratio (aHR) 0.73 (0.66–0.82); dialysis cause-specific HR 0.65 (0.61–0.69), although crude dialysis incidence was nearly identical (90.9% vs 91.2%)Observational, no diet data. Associated with better survival, but confounding by indication and healthy-user effects (users are likely followed more closely) are not excluded. Cited by APSN, which still advises against routine use.
Paniagua 2026Multicenter open-label RCT; type 2 diabetes, CKD G3b–G4; 149 included, 122 completed (69 vs 53); recruited 2019–2020LPD 0.6 g/kg/day + KA vs LPD 0.6 alone; 1 yearCystatin C eGFR change −4.29 ± 0.96 vs −8.54 ± 2.19 mL/min (mean ± SEM; mixed-model p = 0.012); creatinine eGFR no difference; no difference in nutrition, admissions, or adverse eventsEmerging diabetes signal on a surrogate, within a dietitian-supported program. Differential attrition, open label, limited modern background therapy, industry funding. Not evidence for tablet-only prescribing.
Tanasescu 2026Single-center retrospective cohort; 75 adults, advanced non-dialysis CKD with chronic heart failure; median 243 daysNo comparator. Prescribed 0.28–0.40 g/kg/day protein, 28–34 kcal/kg/day, KA about 1 tablet/5 kg, with dietitianWeight change −3.99% (Hodges–Lehmann; 95% CI −4.68 to −3.42); ≥5% loss in 29%; chart signs of nutritional deterioration in 33%; calcium rose, phosphorus fellDirectly relevant to cardiology referrals. Weight loss may reflect fluid as well as tissue; no control group. Supports multidimensional nutrition monitoring with weight read against volume status.
Castaneda 2001RCT; 26 older adults, moderate CKD, stabilized on LPD 0.6 g/kg/dayLPD + resistance training vs LPD alone; 12 weeks; no ketoanaloguesTotal body potassium +4%; type I/II fiber area +24%/+22%; leucine oxidation fell; weight maintained; strength +32% vs −13%Activity counteracts the catabolism of a low-protein diet. Small and short; extension to KA-VLPD is inferred.
ADHERENCE 2026Multicenter RCT, advanced CKD; indexed abstract reports 33 participantsKA-supplemented VLPD implementation and adherenceResearch pending. Full methods and results not independently extracted; no result is used in this guide.

Why the trials disagree

Garneata selected roughly one in seven screened patients for nutritional status and demonstrated adherence before randomization, then delivered a vegetarian pattern with the supplement; the intervention therefore changed protein quantity, protein source, phosphate and acid load, and amino-acid supply at once. ERIKA tested what happens when the same idea is prescribed to the patients a nephrology clinic actually sees: the achieved contrast shrank from 0.35 vs 0.60 to 0.60 vs 0.83 g/kg/day, and with it any detectable difference. The honest synthesis is that a supplemented VLPD can work when it is truly delivered to a carefully selected patient — and that a prescription alone does not deliver it. Neither trial was done on top of sodium-glucose cotransporter 2 (SGLT2) inhibitors, finerenone, or glucagon-like peptide-1 (GLP-1) receptor agonists, so the incremental value over contemporary drug therapy is unknown.

Absolute numbers for the patient conversation

In Garneata, about 29 of every 100 selected patients avoided the composite over 15 months with the program (42% vs 13%). That magnitude belongs to that population and that program. It should not be transferred to routine tablet prescribing, applied to a Kidney Failure Risk Equation result, or quoted to a patient eating an unrestricted diet.

Proposed care checklist and handoff

This is a proposed care checklist, not a validated eligibility score. It carries no points, no pass mark, and no green “eligible” state; a completed form does not authorize prescribing. A missing item should read “not documented,” never “normal.”

Flowchart titled Before the first ketoanalogue tablet: for nondialysis adult CKD, if already prescribed, review with the prescriber and do not stop abruptly; otherwise document goal and kidney and weight trends, get nephrology and dietitian food protein, energy and reference weight, reconcile shakes, supplements and calcium, and name a monitoring owner and review date; side boxes say assess before restriction if unstable or frail and seek emergency care for urgent symptoms, and a bracket says continue other kidney care.

The handoff pathway: goal, written food and energy prescription, medication and calcium reconciliation, monitoring owner. Current users are reviewed, not stopped; other kidney care continues meanwhile.The handoff pathway: goal, written food and energy prescription, medication and calcium reconciliation, monitoring owner. Current users are reviewed, not stopped; other kidney care continues meanwhile.The handoff pathway: goal, written food and energy prescription, medication and calcium reconciliation, monitoring owner. Current users are reviewed, not stopped; other kidney care continues meanwhile.The handoff pathway: goal, written food and energy prescription, medication and calcium reconciliation, monitoring owner. Current users are reviewed, not stopped; other kidney care continues meanwhile.

CKD
Chronic kidney disease

Copy-ready referral note (edit for local use):

REQUEST: NEPHROLOGY + RENAL NUTRITION REVIEW BEFORE KETOANALOGUE START I am requesting nephrology and renal nutrition review before initiating ketoanalogues. Reason considered / patient goal: ___ eGFR trend (values, dates): ___ | urine ACR: ___ | dialysis: no Diabetes ___ | heart failure/edema ___ | recent illness ___ | appetite/weight trend ___ Current intake (24-h recall or diary): ___ Nutrition products (name, protein g/serving, servings/day): ___ Calcium sources (product, elemental mg/day): ___ | vitamin D: ___ Concerns: ___ Please return a shared food prescription (protein g/day, energy kcal/day, reference weight and basis) and a monitoring plan if supplementation is appropriate. Interim care (BP, glucose, RAS blockade, SGLT2i, other) continues under: ___

What to watch once a supervised plan is running

DomainWhat to recordWhy
Actual intakeDiet recall or record; every shake and supplement by label; who cooksDetects both escalation and over-restriction; the prescription is only as good as what is eaten
Energy and body compositionWeight interpreted against edema, diuretic changes, and dry-weight assessment; muscle and function where feasibleWeight loss on a VLPD can be tissue or fluid; a raw scale change is not a nutritional verdict
Function and activityChair-stand count, gait speed, or grip strength; minutes of activity and resistance sessions per weekFunction is the outcome muscle protein synthesis serves; declining function on a restricted diet is a reassessment trigger
Kidney measuresCreatinine and cystatin C eGFR trends with dates; ACRDiet changes creatinine generation; use more than one marker and the trend
UreaSerum urea or blood urea nitrogen (BUN); urinary urea when a dietitian uses nitrogen-appearance methodsA falling urea is consistent with lower nitrogen intake but also with poor intake; interpret with energy
Minerals and acid–baseCalcium, phosphate, parathyroid hormone (PTH) as indicated; bicarbonate; potassiumCalcium salts add exposure; restriction changes phosphate and acid load; acidosis drives muscle and branched-chain keto-acid oxidation; plant-forward diets change potassium intake
BurdenPill count, cost, missed doses, food-plan feasibilityAn unaffordable or unfollowable plan is a reason to reassess, not to escalate

The interval is set by the treating team for the individual patient; this guide intentionally offers no universal schedule.

Five scenarios from clinic

Case A — Tablets, no food plan, then a strength shake Illustrative

An outpatient with stable CKD G4 received ketoanalogues at a general clinic but no written food prescription. Weeks later he added a 25 g “strength” shake daily, believing the tablets cover it. Action: reconcile actual intake with the protein ledger, coordinate the nutrition plan, and keep other kidney-protective care unchanged. If the shake was meant to build strength, offer the alternative that actually does: a resistance-training plan within the written diet. Do not label the extra intake as the proven cause of a later creatinine change.

Case B — Chronic lung disease, poor appetite Illustrative

A 74-year-old with CKD G4 and chronic obstructive pulmonary disease (COPD) reports poor appetite and declining strength; a ketoanalogue start is proposed. Action: nutrition and functional assessment first. Frailty and sarcopenia require individualization, and an older adult may need at least 0.8 g/kg/day. Avoid an automatic “CKD means less protein” response. If a restricted plan is later chosen, pair it with supervised resistance and balance training from the start.

Case C — Heart failure after diuresis Illustrative

A patient with heart failure loses 6 kg after diuretic intensification. Action: the clinician chooses and documents the reference weight. The scale change cannot be read automatically as wasting or as improvement; protein and energy rates built on the edematous weight would overshoot.

Case D — Established supervised program Illustrative

A patient has followed a nephrologist- and dietitian-directed supplemented VLPD for a year with stable nutrition. Action: review the existing plan; keep the diet and supplement paired until the responsible clinician reassesses. No blanket “stop now.”

Case E — “Does the 2026 trial mean I should start?” Illustrative

A patient with type 2 diabetes and CKD G3b asks about the new trial. Action: explain that it showed a slower cystatin C decline but no creatinine difference in a dietitian-supported program, that current diabetes guidance keeps protein about 0.8 g/kg/day, and that proven drug therapy comes first.

Each load-bearing claim and how sure we are

ClaimCertaintySource
Analogues accept amino groups by transamination and spare nitrogen when intake is lowEstablished biochemistryCupisti 2026 review; product composition
Tablets cannot offset the nitrogen of a protein shakeEvidence-supported inference (arithmetic)Product composition; this guide's calculation
A selected-patient supplemented vegetarian VLPD reduced KRT or eGFR halvingSingle-center RCTGarneata 2016
Prescribing a supplemented VLPD in routine nephrology care added no benefitPragmatic RCTERIKA 2022
Ketoanalogues slow cystatin C eGFR decline in type 2 diabetesSingle RCT, surrogatePaniagua 2026
Weight falls on KA-VLPD in CKD with heart failureObservational, no controlTanasescu 2026
Patients eat more protein after starting tabletsHypothesis only — not measuredAuthor observation; counseling target
Tablets alone, on an unrestricted diet, prevent kidney failureUnsupportedNo trial
Resistance training counteracts the catabolism of a low-protein dietSmall RCT (no ketoanalogues)Castaneda 2001
Activity helps amino acids formed from ketoanalogues reach muscle rather than ureaEvidence-supported inferenceMuscle physiology; Castaneda 2001
Correcting acidosis spares the branched-chain analogues from oxidationMechanistic hypothesisEnzymology; Cupisti 2026 review
50 mg elemental calcium and 36 mg nitrogen per tabletProduct informationFresenius Kabi summary of product characteristics; MIMS Philippines monograph for a locally marketed brand
Some Philippine-registered ketoanalogue products are over the counterRegulatory recordPhilippine FDA registration DRP-13096
Ketoanalogue use is associated with lower mortality in stage 5 diabetic kidney diseaseObservational, confoundedChen 2021
ADHERENCE trial resultsResearch pending — not usedNefrología 2026, not extracted

Status. Evidence checked 11 November 2026. Guideline wording and grades verified against the full texts (KDIGO 2024, KDOQI 2020, APSN 2025); product composition verified against a Philippine monograph. Read the label of the brand actually dispensed.

Try the CalculatorsSubukan ang mga CalculatorSulayi ang mga CalculatorSubukan ya ing Calculator
⌬
Ketoanalogue Plan Check
Food-and-drink protein vs an existing prescription, target arithmetic from a clinician-chosen weight, elemental calcium ledger, and pill-and-cost planner. Arithmetic only.
Open →
⌬
eGFR (CKD-EPI)
Track the kidney-function trend with dates rather than one value.
Open →
⌬
eGFR with Cystatin C
A second filtration marker when diet or muscle mass distorts creatinine.
Open →
⌬
Kidney Failure Risk Equation
Population risk of kidney failure at 2 and 5 years — context for who is “at risk of kidney failure.”
Open →
⌬
Nutrition Screening
Screen for malnutrition risk before any protein restriction.
Open →
Glossary & abbreviationsTalahulugan at mga daglatTalaan sa mga pulong ug daglatTalatinigan ampo reng daglat terms used in this guide

Abbreviations

ACR
Albumin-to-creatinine ratio — a urine test for protein leak.Albumin-to-creatinine ratio — test sa ihi para sa tagas ng protina.Albumin-to-creatinine ratio — test sa ihi para sa pagtulo sa protina.Albumin-to-creatinine ratio — test king ibi para king tulu ning protina.
ADA
American Diabetes Association.
aHR
Adjusted hazard ratio.
APSN
Asian Pacific Society of Nephrology.
BUN
Blood urea nitrogen — a waste product from protein, measured in blood.Blood urea nitrogen — dumi mula sa protina na sinusukat sa dugo.Blood urea nitrogen — hugaw gikan sa protina nga gisukod sa dugo.Blood urea nitrogen — dinat ibat king protina a susukatan king dala.
CI
Confidence interval.
CKD
Chronic kidney disease — kidney damage or reduced function lasting more than three months.Chronic kidney disease — pinsala o paghina ng bato nang higit sa tatlong buwan.Chronic kidney disease — kadaot o pagkahuyang sa kidney nga molapas sa tulo ka bulan.Chronic kidney disease — kasiran o kalatian ning batu a mayigit tatlung bulan.
COPD
Chronic obstructive pulmonary disease.
DKD
Diabetic kidney disease.
EAA
Essential amino acid.
ERA
European Renal Association.
eGFR
Estimated glomerular filtration rate — an estimate of kidney filtering from a blood test.Estimated glomerular filtration rate — tantiya ng pagsala ng bato mula sa blood test.Estimated glomerular filtration rate — banabana sa pagsala sa kidney gikan sa blood test.Estimated glomerular filtration rate — tantiya ning pamanyala ning batu ibat king blood test.
ESKD
End-stage kidney disease.
FDA
Food and Drug Administration (Philippines).
GLP-1
Glucagon-like peptide-1.
HR
Hazard ratio.
ITT
Intention to treat.
KA
Ketoanalogue — keto- or hydroxy-acid analogue of an essential amino acid.Ketoanalogue — kahalintulad ng essential amino acid na kulang sa nitrogen.Ketoanalogue — kaamgid sa essential amino acid nga kulang sa nitrogen.Ketoanalogue — kalupa ning essential amino acid a kulang king nitrogen.
KDIGO
Kidney Disease: Improving Global Outcomes.
KDOQI
Kidney Disease Outcomes Quality Initiative.
KRT
Kidney replacement therapy — dialysis or transplant.Kidney replacement therapy — dialysis o transplant.Kidney replacement therapy — dialysis o transplant.Kidney replacement therapy — dialysis o transplant.
LPD
Low-protein diet.Low-protein diet — diyetang mababa sa protina.Low-protein diet — diyeta nga ubos sa protina.Low-protein diet — diyeta a mababa king protina.
MIMS
A drug-information reference used by Philippine clinicians and pharmacists.
MDRD
Modification of Diet in Renal Disease study.
NNT
Number needed to treat.
PTH
Parathyroid hormone.
RAS
Renin–angiotensin system.
RCT
Randomized controlled trial.
RD
Renal dietitian.
SEM
Standard error of the mean.
SGLT2
Sodium-glucose cotransporter 2.
VLPD
Very-low-protein diet — about 0.3–0.4 g of protein per kg per day, only under supervision.Very-low-protein diet — mga 0.3–0.4 g protina bawat kg kada araw, may gabay lamang.Very-low-protein diet — mga 0.3–0.4 g protina matag kg kada adlaw, adunay giya lang.Very-low-protein diet — malapit 0.3–0.4 g protina king balang kg king aldo, atin gabay mu.

Terms

Amino acid
The building blocks of protein.Ang maliliit na bahagi ng protina.Ang gagmay nga bahin sa protina.Reng malating bage ning protina.
Elemental calcium
The actual calcium in a product, not the weight of the calcium salt.Ang tunay na calcium sa produkto, hindi ang bigat ng calcium salt.Ang tinuod nga calcium sa produkto, dili ang bug-at sa calcium salt.Ing tutung calcium king produktu, e ing bigat ning calcium salt.
Reference weight
The body weight a clinician chooses to calculate protein and energy targets.Ang timbang na pinipili ng doktor para kuwentahin ang target na protina at enerhiya.Ang timbang nga gipili sa doktor aron kuwentahon ang target nga protina ug enerhiya.Ing timbang a pilinan ning doktor bang kuwentan ing target a protina at enerhiya.
Renal dietitian
A dietitian trained in kidney nutrition who writes and explains the food plan.Dietitian na sinanay sa nutrisyon sa bato na sumusulat at nagpapaliwanag ng plano sa pagkain.Dietitian nga nabansay sa nutrisyon sa kidney nga mosulat ug mopasabot sa plano sa pagkaon.Dietitian a misanay king nutrisyon king batu a manyulat at manyalaysay ning planu king pamangan.
Muscle protein synthesis
The building of new muscle protein from amino acids; switched on by eating protein and by using the muscle.Ang pagbuo ng bagong protina ng kalamnan mula sa amino acid; pinapagana ng pagkain ng protina at ng paggamit ng kalamnan.Ang paghimo og bag-ong protina sa kaunoran gikan sa amino acid; gipalihok sa pagkaon og protina ug sa paggamit sa kaunoran.Ing pamamuo bayung protina ning laman ibat king amino acid; pakilusan ning pamangan protina at ning pamanggamit king laman.
Resistance exercise
Exercise that makes muscles push or pull against weight, such as chair stands or lifting light weights.Ehersisyong nagpapatulak o nagpapahila sa kalamnan laban sa bigat, tulad ng pagtayo mula sa upuan o pagbuhat ng magaang pabigat.Ehersisyo nga mopatulod o mopabira sa kaunoran batok sa bug-at, sama sa pagtindog gikan sa lingkuranan o pag-alsa og gaan nga pabug-at.Ehersisyu a pamatulak o pamabatak king laman laban king bigat, antimo ing pamikatalakad ibat king upuan o pamuat magaan a pabigat.
Teach-back
Saying the plan back in your own words so the team knows it was clear.Pag-uulit ng plano sa sarili mong salita para malaman ng team na malinaw ito.Pagsubli sa plano sa imong kaugalingong pulong aron mahibaloan sa team nga klaro kini.Pamanulit ning planu king sariling amanu mu bang balu ning team a malino ya.
Transamination
Transfer of an amino group from one molecule to another; how ketoanalogues become amino acids.
Urea
The main nitrogen waste made from protein, removed by the kidneys.Ang pangunahing nitrogen na dumi mula sa protina, inilalabas ng bato.Ang pangunang nitrogen nga hugaw gikan sa protina, gipagawas sa kidney.Ing pangunang nitrogen a dinat ibat king protina, ilwal ning batu.
ReferencesMga SanggunianMga TinubdanReng Reperensya 15 sources
  1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2024). KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International, 105(4S), S117–S314. https://doi.org/10.1016/j.kint.2023.10.018
  2. Ikizler, T. A., Burrowes, J. D., Byham-Gray, L. D., Campbell, K. L., Carrero, J.-J., Chan, W., Fouque, D., Friedman, A. N., Ghaddar, S., Goldstein-Fuchs, D. J., Kaysen, G. A., Kopple, J. D., Teta, D., Yee-Moon Wang, A., & Cuppari, L. (2020). KDOQI clinical practice guideline for nutrition in CKD: 2020 update. American Journal of Kidney Diseases, 76(3 Suppl 1), S1–S107. https://doi.org/10.1053/j.ajkd.2020.05.006
  3. American Diabetes Association (ADA) Professional Practice Committee. (2026). 11. Chronic kidney disease and risk management: Standards of Care in Diabetes—2026. Diabetes Care, 49(Suppl 1), S246–S260. https://doi.org/10.2337/dc26-S011
  4. Liew, A., Bavanandan, S., Hao, C.-M., Lim, S. K., Prasad, N., Sahay, M., Susantitaphong, P., Roberts, V., Wijewickrama, E., Wong, M. G., & Tang, S. C. W. (2025). Asian Pacific Society of Nephrology clinical practice guideline on diabetic kidney disease—2025 update. Nephrology, 30(Suppl 2), 3–56. https://doi.org/10.1111/nep.70030
  5. Garneata, L., Stancu, A., Dragomir, D., Stefan, G., & Mircescu, G. (2016). Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology, 27(7), 2164–2176. https://doi.org/10.1681/ASN.2015040369
  6. Bellizzi, V., Signoriello, S., Minutolo, R., Di Iorio, B., Nazzaro, P., Garofalo, C., Calella, P., Chiodini, P., & De Nicola, L. (2022). No additional benefit of prescribing a very low-protein diet in patients with advanced chronic kidney disease under regular nephrology care: A pragmatic, randomized, controlled trial. The American Journal of Clinical Nutrition, 115(5), 1404–1417. https://doi.org/10.1093/ajcn/nqab417
  7. Menon, V., Kopple, J. D., Wang, X., Beck, G. J., Collins, A. J., Kusek, J. W., Greene, T., Levey, A. S., & Sarnak, M. J. (2009). Effect of a very low-protein diet on outcomes: Long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases, 53(2), 208–217. https://doi.org/10.1053/j.ajkd.2008.08.009
  8. Chen, C.-H., Tsai, P.-H., Tsai, W.-C., Ko, M.-J., Hsu, L.-Y., Chien, K.-L., Hung, K.-Y., & Wu, H.-Y. (2024). Efficacy and safety of ketoanalogue supplementation combined with protein-restricted diets in advanced chronic kidney disease: A systematic review and meta-analysis. Journal of Nephrology, 37(8), 2113–2125. https://doi.org/10.1007/s40620-024-02065-9
  9. Paniagua, R., Ávila-Díaz, M., Nava, J., Romero-Salas, R., Hernández-Rivera, J. C. H., Mejía-Rodríguez, O., Picolli, G. B., & Mexican Nephrology Collaborative Study Group. (2026). Low-protein diet supplemented with ketoanalogues and progression of chronic kidney disease in diabetic patients: A multicenter randomized controlled trial. Nutrients, 18(16), 2630. https://doi.org/10.3390/nu18162630
  10. Tanasescu, M. D., Rosu, A. M., Minca, A., Andrieș Ioniță, E. I., Timofte, D., Constantin, L. D., Voiculescu, D. I., & Ionescu, D. (2026). Longitudinal nutritional and cardiorenal changes among patients prescribed a ketoanalogue-supplemented very-low-protein diet in advanced nondialysis chronic kidney disease with chronic heart failure: A retrospective cohort study. Nutrients, 18(18), 3069. https://doi.org/10.3390/nu18183069
  11. Cupisti, A., D'Alessandro, C., Panichi, V., Moriconi, D., & Giannese, D. (2026). Ketoanalogues of essential amino acids in chronic kidney disease: From biochemical rationale to conditions for clinical effectiveness. Nutrients, 18(19), 3157. https://doi.org/10.3390/nu18193157
  12. Castaneda, C., Gordon, P. L., Uhlin, K. L., Levey, A. S., Kehayias, J. J., Dwyer, J. T., Fielding, R. A., Roubenoff, R., & Singh, M. F. (2001). Resistance training to counteract the catabolism of a low-protein diet in patients with chronic renal insufficiency: A randomized, controlled trial. Annals of Internal Medicine, 135(11), 965–976. https://doi.org/10.7326/0003-4819-135-11-200112040-00008
  13. Fresenius Kabi (FK). (2014). Ketosteril film-coated tablets: Summary of product characteristics. Manufacturer information from one market; verify the locally approved Philippine label. https://vardgivare.skane.se/siteassets/2.-patientadministration/bestall-produkter-och-tjanster/lakemedel/licenslakemedel/smpc_ketosteril_2014.pdf
  14. Chen, H.-Y., Sun, C.-Y., Lee, C.-C., Wu, I.-W., Chen, Y.-C., Lin, Y.-H., Fang, W.-C., & Pan, H.-C. (2021). Ketoanalogue supplements reduce mortality in patients with pre-dialysis advanced diabetic kidney disease: A nationwide population-based study. Clinical Nutrition, 40(6), 4149–4160. https://doi.org/10.1016/j.clnu.2021.01.045
  15. Food and Drug Administration Philippines (FDA). (2022). Ketomirin (ketoanalogues + essential amino acids) 630 mg film-coated tablet, DRP-13096: Drug registration record (over-the-counter). Retrieved November 11, 2026, from https://trial.medpath.com/drug/approvals/philippines/c31195be99246ee7
Dr. W Rivero, MD

W Rivero, MD, FPCP, DPSN

Specialist in Internal Medicine, Nephrology, and Clinical Nutrition. Practicing integrative and evidence-based nephrology across Quezon City, Pampanga, and Bulacan.

· Book an Appointment →

QR code — scan to save Dr. Rivero's contact info

Scan and save